French study tracks Dupilumab's Real-World impact on severe nasal polyps
NCT ID NCT06393946
First seen Jan 10, 2026 · Last updated May 09, 2026 · Updated 18 times
Summary
This study follows 150 adults in France with severe chronic sinusitis and nasal polyps who are taking dupilumab (Dupixent). Researchers will describe patient characteristics, past treatments, and how symptoms change over two years. The goal is to understand real-world use and safety, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number: 250.0001
Nantes, 44093, France
Conditions
Explore the condition pages connected to this study.